Institute for Atherosclerosis Research, Russia Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Moscow Russian Federation

Organization Overview

First Clinical Trial
2005
NCT01741974
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Institute for Atherosclerosis Research, Russia

Active Ingredients

Drugs in Phase 3 Trials (1)

yogurt bacteria (2 trials)

Drugs in Phase 2 Trials (1)

inflaminat (1 trial)

Drugs in Other Trials (4)

cocarboxylase (1 trial)

cyanocobalamin (berocca) (1 trial)

disodium adenosine triphosphate (1 trial)

nicotinamide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Carotid Artery Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6